Nessuna offerta aperta al momento.
Daiichi Sankyo Europe GmbH, part of the Daiichi Sankyo group, announced the elimination of approximately 280 U.S. jobs as part of a restructuring to better align its commercial operations with its current portfolio of marketed drugs and pipeline of cancer treatments.
www.genengnews.com